Abstract 5174: Phosphodiesterase 10A inhibition as a novel approach to suppress β-catenin signaling in ovarian cancer cells
Luciana Madeira da Silva(USA Mitchell Cancer Institute), Gary A. Piazza(Auburn University), Alla Musiyenko(USA Mitchell Cancer Institute), Rodney P. Rocconi(University of Mississippi Medical Center), Kevin J. Lee(University of Alabama at Birmingham), Ileana Aragon(University of South Alabama), Holly Taylor(USA Mitchell Cancer Institute), Elaine Gavin(USA Mitchell Cancer Institute), Kristy Berry(USA Mitchell Cancer Institute), Verónica Ramírez‐Alcántara(USA Mitchell Cancer Institute), Jennifer Scalici(University of Virginia Health System), Adam B. Keeton(Washburn University)
Cited by 1
Related Papers
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Ligand steric properties
|Coordination Chemistry Reviews|1993|210
ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
|PLoS ONE|2014|169
Cardiac Troponin I Gene Knockout
|Circulation Research|1999|157
Frailty: An outcome predictor for elderly gynecologic oncology patients
|Gynecologic Oncology|2012|140